Liver Diseases  >>  Intron A (interferon α-2b)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Intron A (interferon α-2b) / Merck (MSD), Biogen
NCT01430000: Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Withdrawn
1/2
0
RoW
Subcutan implantation of autologus skin graft after ex-vivo treatment
Medgenics Medical Israel Ltd.
Hepatitis C
 
 

Download Options